“…3) there is no peak indicating an H atom at the bridging N atom; (iii) there are peaks in the difference map indicating that both imidazolidine N atoms are protonated. Additionally a comparison with another ten known solvent-free derivatives of (I) in the Cambridge Structural Database (CSD; Allen, 2002) revealed that all of them show the 2-imino-imidazolidine tautomeric form (Ib) [CSD refcodes ALALEF (Saczewski et al, 2011), GOLNIE (Elssfah et al, 1999a), HIGGOU (Begum & Vasundhara, 2007), HODQOG (Elssfah et al, 1999b), KIBRAO (Koch et al, 1990), LUVPOH (Varga et al, 2003), QIBBOS (Isobe et al, 2000), VOVCUE01 (Schrö der et al, 2003), XERHOS (Kornicka et al, 2006) and ZAYQOF (Dupont et al, 1995)]. Finally, 1 H NMR measurements show that (for the -CH 2 group), instead of two different signals, as would be expected for the asymmetrical 2-aminoimidazoline tautomer (Ia), only one signal appeared, indicating the symmetrical 2-imino-imidazolidine tautomer (Ib).…”